AURO-DEFERASIROX (TYPE J)

Identification of Auro-Deferasirox (Type J)

No description

Google image searchProduct monograph

Active ingredient

deferasirox, 180 MG

DIN: 02527782

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: AURO PHARMA INC

Date: 14-AUG-2024

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AC — Iron chelating agents (ATC, ATC/DDD)
• V03AC03 — DEFERASIROX (ATC/DDD)

Reference brand drug: Exjade

Pharmaceutical standard: MFR

External Links for Auro-Deferasirox (Type J)

Search on Google

• Auro-Deferasirox (Type J) side effects
• Auro-Deferasirox (Type J) dosage
• deferasirox side effects
• deferasirox dosage

Auro Pharma Inc

Go to Auro Pharma website to see drug product details. Sometimes you can find auro-deferasirox (type j) photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.